Table of Contents
- What is Hyperlipidemia?
- What Are The Causes?
- Do Natural Treatments Work?
- Other Treatment Options.
What is Hyperlipidemia?
Hyperlipidemia is a key preventable risk factor for the number one cause of death and disability in the developed world – heart disease. Hyperlipidemia refers to high levels of lipids in the blood.
Hyperlipidemia (also called dyslipidemia) can be asymptomatic (until you get really sick or it kills you) but can be diagnosed from a simple blood test. Sometimes, high blood lipid levels can actually form a fat globule which floats on top of blood samples in a test tube like a oil slick. Doctors can also suspect hyerplipidemia from deposits of lipids seen in the eyes called xanthelasma.
Cholesterol is a waxy fat-like substance that is a key ingredient in cell synthesis. Simply put, cholesterol is critical to our survival as a species. There are two main sources of cholesterol. We make cholesterol in our liver and also consume cholesterol as part of our diet.
Cholesterol is carried around in the blood stream in small packages which are made up of lipids and proteins called lipoproteins. Not all forms of cholesterol are created equally. There are two main types of lipoprotein, one called low density lipoprotein (LDL) and the other called high density lipoprotein (HDL).
LDL-cholesterol makes up 60% of the total cholesterol and is a major risk factor for heart disease, while HDL-cholesterol is cardioprotective. Sometimes LDL is called bad cholesterol and HDL is called good cholesterol.
A housekeeping analogy is often used to explain the difference between LDL-cholesterol and HDL-cholesterol to patients (like all analogies it works best for some people who relate to it more than others, but here goes). LDL- cholesterol is the untidy teenager who goes around the house dropping things anywhere and everywhere. HDL-cholesterol is the house proud mom who goes around putting things away.
In general it is a bad idea to drop off cholesterol in the arteries because it enters the lining of the arteries and triggers a chain reaction that ultimately leads to narrowing or blockage of the arteries (aka angina and heart attacks).
What Are The Causes?
Causes of dyslipidemia can be divided in two main categories:
Primary dyslipidemia where people are born with an inherited disorder of lipid metabolism.
Secondary dyslipidemia caused by:
- Metabolic diseases eg type 2 diabetes
- Endocrine disorders eg hypothyroidism
- Liver disease e.g. alcoholic cirrhosis
- Renal disease e.g. chronic renal failure
- Medications e.g. antiretroviral medication used to treat HIV
- Lifestyle causes e.g. cigarette smoking, obesity, physical inactivity, diet rich in fats, alcohol excess.
Do Natural Treatments Work?
Given the size of the potential market for natural therapies for hyperlipidemia (20% of people in their twenties and 60% of people over the age of 50), it is not surprising that there is significant chatter on the internet about natural therapies for hyperlidemia.
A wide range of natural treatments have been touted as ‘safe and effective’ alternatives or adjuncts to managing hyperlipidemia including fish oil, red yeast rice, niacin, chromium, milk thistle, garlic. Sounds like we should unbox some of these options and see what science there is to back up any of these claims.
Will Fish Oil Help?
In 2012, 7.8% of the adult American population (18.8 million people) reported taking fish oil, predominantly non-prescription omega-3 fish oil. (1).
A key meta-analysis of cardiovascular outcomes (including mortality) with omega-3 therapy was published in 2012 (2). The researchers looked at 20 studies in 63030 people with and without known heart disease. They found no benefit of omega-3 supplementation in terms of cardiovascular outcomes or death.
A consortium from the American Heart Association Nutrition Committee published a consensus position paper on omega-3 supplementation in the journal Circulation earlier this year. (3). They reviewed randomized controlled trials of omega-3 supplementation that had major cardiovascular end-points.
They undertook the review to account for new studies which had been published since the 2012 meta-analysis. They concluded that omega-3 supplementation was ‘reasonable’ in patients with known cardiovascular disease (such as a recent heart attack).
However they could not comment on its use in people with no cardiovascular disease as there are no reported studies of omega-3 in primary prevention (prevention of heart disease in healthy people with no heart disease).
Summary: Currently omega-3 is recommended for people who have known heart disease but there is no information on its utility in healthy people with no known pre-existing heart disease.
Will Red Yeast Rice Help?
Red yeast rice contains Monacolin K (lovastatin) and is widely used as a herbal medicine in China. Investigators in China and Italy conducted a comprehensive meta-analysis to explore the safety and efficacy of red yeast rice in dysplipidemia (4).
They analyzed data from 804 subjects who participated in 13 randomized placebo controlled trials. The study showed that red yeast rice significantly lowered total cholesterol, LDL-cholesterol but not HDL-cholesterol as compared to placebo. No significant side effects were noted. Mild muscle pain as the most common side effect reported.
Summary: There is science to support the claim that red yeast rice can help hyperlipidemia. However, further long-term, rigorously designed randomized controlled trials are still warranted before red yeast rice could be recommended to patients with dyslipidemia, especially as an alternative to statins.
Will Niacin Help?
Niacin (B3 or nicotinic acid) is known to reduce total cholesterol and triglycerides and increase HDL-cholesterol (5). Using linear reductionist thinking, niacin should help reduce heart disease given the fact that it has a favorable lipid profile. However a new meta-analysis of clinical outcomes with niacin just published this summer has found that this is not the case. I think we can all agree that we care about clinical outcomes and not laboratory values.
A Cochrane review evaluated the impact of niacin on the risk of heart disease or stroke (6). Investigators identified 23 studies (including 39195 participants) that did head-to-head comparisons of niacin versus placebo. 17 out of the 23 studies were fully or partially funded by companies with manufacturing interests in the compound.
Niacin offered no benefits in terms of death, heart attacks or stroke over placebo. The authors concluded that cardiovascular benefits from niacin therapy are ‘unlikely’.
Summary: Cochrane reviewers say that niacin is ‘unlikely’ to help with cardiovascular outcome benefits.
Will Chromium Help?
Chromium is an essential mineral for carbohydrate and lipid metabolism. A meta-analysis of 22 randomized control trials of chromium mono-supplementation in diabetes showed that chromium significantly reduced triglycerides and increased HDL levels (7). There were no significant differences between the side effect profile of chromium versus placebos.
A double blind cross-over study in non-diabetic healthy volunteers also showed that chromium 200micrograms had a favorable effect on lipid profiles (8).
Summary: There is evidence to suggest that chromium supplementation can have a favorable impact on lipid profiles in patients with diabetes.
Will Milk Thistle Help?
There are no clinical studies evaluating the effect of milk thistle (Silybum marianum) on lipid profiles.
There is a study which looked at the combination of Berberis aristata (tree turmeric) plus Silybum marianum on lipid profiles in patients who were intolerant of standard statin therapy (9). 137 dyslipidemia patients were enrolled in the study. All patents had experienced treatment limiting side-effects on statin therapy.
The statin therapy was discontinued for one month and then re-introduced at half the original dose. Patients were then randomly assigned to either B. aristata/S. marianum 558/105mg twice daily with meals for six months.
Lipid profiles did not change in the intervention arm but increased in the placebo arm. There were no significant adverse effects noted. The authors concluded that B. aristata/S. marianum may be considered as adjunctive therapy in patients intolerant of standard statin therapy.
A second study looked at a combination of red yeast rice plus S. marianum plus octasonal versus placebo on the lipid profiles of 134 low risk dyslipidemic patients (10). There was a non-significant decrease in total cholesterol and LDL- cholesterol compared to baseline in the intervention group.
Summary: There are no studies looking at milk thistle mono-therapy on lipid profiles.
Will Garlic Help?
An updated comprehensive meta-analysis of garlic on serum lipids reviewed data from 39 primary trials (11). The review showed that garlic was well tolerated and was associated with a 17 +/- 6mg/dl reduction in total cholesterol and a 9+/-6mg/dl reduction in LDL-cholesterol but had no significant impact on HDL-cholesterol or triglycerides.
Summary: The scientific literature suggests that garlic may benefit serum lipid profiles.
Other Treatment Options.
Once a diagnosis of hyperlipidemia is made, physicians usually take a comprehensive personal and family history and do a full physical examination to identify any relevant disorders such as strong family history of early heart disease (suggesting familial hyperlipidemia), thyroid, renal, liver disease etc.
Hyperlipidemia is not (should not be) managed in isolation. Physicians use an overall heart disease risk score calculator ((e.g. QRISK) )which combines a range of key risk factors for heart disease and gives an overall risk score for heart disease which is then used to plan the care plan for that patient (12).
As an example, people with hyperlipidemia plus hypertension plus diabetes would have a higher QRISK score than a fit younger person with normal blood pressure.
There is a graded relationship between LDL-cholesterol and heart disease and lowering LDL-cholesterol reduces cardiovascular events in patients with and without cardiovascular disease (13).
The vast majority of people have no identifiable risk factor for hyperlipidemia other than lifestyle issues. Oddly, (speaking as a practising physician), I can honestly say that it is often easier to manage thyroid or renal disease than to attempt to conquer lifestyle issues.
Will Diet & Exercise Help?
It is standard practice to recommend lifestyle modifications including weight loss, exercise and a healthy diet to all patients with hyperlipidemia. Believe me, when I say that it is far easier (and faster and more popular) to write a prescription that it is to have ‘that conversation’ with some patients.
Studies have shown that exercise increases LDL size (14).
A UK based study in 2508 subjects showed that 60% of people achieved a 1.8% reduction in body weight which was associated with a 5 to 7% decrease in total and LDL-cholesterol (15).
Summary: Lifestyle modification is a cornerstone of the management of hyperlipidemia.
Will Statins Help?
Statins remain the mainstay of drug therapy for hyperlipidemia. A Cochrane review of randomized trials of stains versus placebo or standard of care showed a reduction in all cause mortality and major vascular events with no excess of side effects in adults with no evidence of heart disease who were treated with statins (16). The Cochrane review included 19 high quality randomised control trials including over 56,000 participants.
Bottom line: High quality evidence demonstrates that Statins are effective in the management of hyperlipidemia.
There are a wide range of statins (branded and generic) on the market and 18 million Americans take statins daily. Key side effects include headache, fatigue, altered bowel habit. A signature side effect of statins is inflammation of muscles which can cause muscle pain and renal damage. Sometimes statin medications have to be withheld to facilitate co-prescription of other medications (e.g. daptomycin used to treat MRSA infection) because of a risk of additive toxicity.
Will Meditation Help?
Meditation and mindfulness are believed to afford a range of health benefits. A controlled trial evaluated the effect of one year of Transcendental Mediation on serum cholesterol levels in patients with hypercholesterolemia (17). Paired comparisons were made between regular meditators and non-meditators and found a statistically significant reduction in cholesterol among the meditators.
This study has a number of limitations including a small sample size (n=23) and the fact that meditators may have had an overall healthier lifestyle which could have confounded the results.
Summary: There is no convincing evidence to support the use of meditation for hyperlipidemia (though there are plenty of other reasons to recommend meditation).
Will Proprotein convertase subtilsin kexin 9 (PCSK9) Help?
Proprotein convertase subtilsin kexin 9 (PCSK9) is a new type of treatment for hyperlipidemia with a novel mode of action (18). It acts by reducing LDL receptor recycling on cell walls which increases circulating levels of LDL. Currently studies are underway to assess the safety and efficacy of this agent in primary prevention.
However, it is currently administered by injection (as opposed to orally) and is expensive which means it is only likely to be of relevance to a high-risk sub-group of patients with hyperlipidemia.
Summary: It is too early to comment on proprotein convertase subtilsin kexin 9 but practical issues make it unlikely to be a runner.
There are a number of proven modalities which can effectively correct hyperlipidemia. While hyperlipidemia in adults is important, this is a very narrow lens through which to view health. Lipids are just a part of a bigger matrix that affects our health and longevity. It is much more important to look at overall cardiovascular risk such as the QRISK score.
In reality, many people prefer quick-fixes (statins) over fit-bits. The true impact of correcting LDL levels (by natural or pharmaceutical means) will be very limited if done without consideration of other related risk factors such as weight, exercise, cigarette smoking etc.
Equally, it is a mistake to focus just on adults. Children are also at risk of hyperlipidemia (19).
So often, people are fixated on the relative merits of natural (herbal) versus pharmaceutical therapies. When it comes to hyperlipidemia, such conversations are missing the point entirely. The focus should not be natural versus pharmaceutical. I have patients who regularly eat at fast food joints and rarely exercise as they are really busy. These same patients have an aversion to pharmaceutical drugs and will only take fish-oil, garlic and milk thistle. I advise them to pick their battles.
There is a much bigger picture here.
For many people (like these patients), hyperlipidemia is probably best viewed as an early warning system that alerts us to a much bigger lifestyle problem.
- Trends in the use of complementary health approaches among adults: United States, 2002-2012. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Natl Health Stat Report. 2015 Feb 10;(79):1-16.
- Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):808-18. doi: 10.1161/CIRCOUTCOMES.112.966168. Epub 2012 Oct 30. Review.
- Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology.
- A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia Yinhua Li, Long Jiang, Zhangrong Jia, Wei Xin, Shiwei Yang, Qiu Yang, Luya Wang PLoS One. 2014; 9(6): e98611. Published online 2014 Jun 4. doi: 10.1371/journal.pone.0098611
- Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES. J Am Coll Cardiol. 2005 Jan 18;45(2):185-97.
- Niacin for primary and secondary prevention of cardiovascular events. Schandelmaier S, Briel M, Saccilotto R, Olu KK, Arpagaus A, Hemkens LG, Nordmann AJ. Cochrane Database Syst Rev. 2017 Jun 14;6:CD009744. doi: 10.1002/14651858.CD009744.pub2. Review.
- Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. N, Poolsup N, Yuwanakorn A. J Clin Pharm Ther. 2014 Jun;39(3):292-306. doi: 10.1111/jcpt.12147. Epub 2014 Mar 17. Review.
- The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. Press RI, Geller J, Evans GW. West J Med. 1990 Jan;152(1):41-5.
- Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. Derosa G, Romano D, D’Angelo A, Maffioli P. Atherosclerosis. 2015 Mar;239(1):87-92. doi: 10.1016/j.atherosclerosis.2014.12.043. Epub 2014 Dec 24.
- A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters. Derosa G, Bonaventura A, Bianchi L, Romano D, D’Angelo A, Fogari E, Maffioli P. J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):317-24.
- Effect of garlic on serum lipids: an updated meta-analysis. Ried K, Toben C, Fakler P. Nutr Rev. 2013 May;71(5):282-99. doi: 10.1111/nure.12012. Epub 2013 Mar 7. Review.
- Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Zavaroni I, Dall’Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A, Butturini U. Atherosclerosis. 1985 Jun;55(3):259-66.
- Effects of the amount and intensity of exercise on plasma lipoproteins. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA. N Engl J Med. 2002 Nov 7;347(19):1483-92.
- Usual care dietary practice, achievement and implications for medication in the management of hypercholesterolaemia. Data from the U.K. Lipid Clinics Programme. Butowski PF et al. Eur Heart J. (1998)
- Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816. doi: 10.1002/14651858.CD004816.pub5. Review.
- Cooper MJ, Aygen MM. A relaxation technique in the management of hypercholesterolemia. Journal of human stress 5(4):24-7 Dec, 1979
- PCSK9: a key modulator of cardiovascular health. Seidah NG, Awan Z, Chrétien M, Mbikay M. Circ Res. 2014 Mar 14;114(6):1022-36. doi: 10.1161/CIRCRESAHA.114.301621. Review
- Update on pediatric hyperlipidemia. Shaun A, Plunkier P. Curr Opin Podiatry. 2014 Apr;26(2):252-8. doi: 10.1097/MOP.0000000000000078. Review.